Market Pulse
Daily · Sep 21, 2026 · data.go.kr + ECOS
KOSPI
7,007.72
+113.49 (+1.65%)
KOSDAQ
836.27
+9.15 (+1.11%)
KOSPI 200
1,112.16
+21.93 (+2.01%)
USD/KRW
1,381.00
006280KOSPI·May 11, 2026
Alyglo performance beats expectations
Mirae Asset Securities published a company analysis report on GC Biopharma Corp. (006280) titled "Alyglo performance beats expectations".
Summary
Covers GC Biopharma Corp. (006280).
Covered stock
More on 006280
2Q26 preview: Earnings set to improve in 2HMirae Asset Securities · Jul 23, 20264Q25 preview: Alyglo growth to ease concernsMirae Asset Securities · Jan 16, 20263Q25 review: In-line resultsMirae Asset Securities · Nov 04, 20252Q25 results likely to ease concernsMirae Asset Securities · Jul 23, 2025Earnings improve on increased sales of high-margin productsMirae Asset Securities · May 07, 2025Profit turnaround expected on favorable product mixMirae Asset Securities · Apr 17, 2025